progress_bar test
Program | Target | Lead optimization | Pre-clinical | IND enabling | Phase 1 |
---|---|---|---|---|---|
Covid-19 therapeutics antibody | |||||
ATBM-36M | Spike/Covid-19 | ||||
ATBM-14M | Spike/Covid-19 | ||||
Cancer therapeutics antibody | |||||
SLAM7-53 | SLAM7/MM | ||||
Neobody-101 | Undisclosed | ||||
Cancer CAR-T therapy | |||||
ATBM-CarT1 | Undisclosed |